Kiora Pharmaceuticals, Inc. KPRX
As ofNov 20, 2026, 12:07 PM EST
- YTD
- -62.69%
- 1 year
- -59.17%
Held by funds
5 US ETFs and mutual funds hold KPRX · largest positions
Ownership
- Institutions 48.3%
- Insiders 2.31%
- Public and other holders 49.3%
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Rosalind Advisors, Inc. | 8.52% | 255,555 | 840.77K | Sep 29, 2024 |
| AIGH Capital Management LLC | 8.52% | 255,555 | 840.77K | Sep 29, 2024 |
| Nantahala Capital Management, LLC | 7.04% | 211,110 | 694.55K | Sep 29, 2024 |
| Stonepine Capital Management, LLC | 6.74% | 202,400 | 665.89K | Sep 29, 2024 |
| Adar1 Capital Management, LLC | 6.55% | 196,551 | 646.65K | Sep 29, 2024 |
| Alyeska Investment Group, L.p. | 6.02% | 180,780 | 594.77K | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.45% | 13,435 | 44.20K | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 0.09% | 2,729 | 8.98K | Sep 29, 2024 |
| Bridgeway Fds Inc-Omni Small Cap Value Fund | 0.07% | 2,000 | 6.58K | Sep 29, 2024 |
| Fidelity Series Total Market Index Fund | 0.05% | 1,413 | 4.65K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.02% | 747 | 2.46K | Oct 30, 2024 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Leadership team
Who runs KPRX, and what each was last paid
Brian Strem, President, Chief Executive Officer & DirectorAverage age 46
| Name | Title | Pay | Age |
|---|---|---|---|
| Brian Strem | President, Chief Executive Officer & Director | $839K | 46 |
| Melissa Tosca | Chief Financial Officer | $452K | 46 |
| Stefan Sperl | Executive Vice President of CMC & Operations | — | — |
| Keith J. Lane | Executive VP and Head of Clinical Development & Regulatory Affairs | — | 45 |
Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| DANIELS ERIC JOSEPH | Officer | Stock Award(Grant) | Jun 30, 2024 | 18,577 |
| PARSONS ERIN | Director | Purchase | Jun 12, 2024 | 0 |
| SHAPIRO ARON | Director | Purchase | Sep 9, 2024 | 0 |
| STENGONE CARMINE N | Director | Purchase | Sep 10, 2024 | 1,250 |
| STREM BRIAN M. | Chief Executive Officer | Stock Award(Grant) | Jun 30, 2024 | 30,160 |
| TOSCA MELISSA | Chief Financial Officer | Purchase | Aug 13, 2024 | 13,599 |
